Home › Stocks › GDTC

GDTC — CYTOMED THERAPEUTICS LIMITED

Reported value held$220.63K
Funds holding (latest)12
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)6
Institutional value$115.67K · 135.90K sh
New / Add / Cut / Exit4 / 1 / 0 / 1 · Updated 2026-11-17
Top-5 / Top-10 concentration100.0% / 100.0%
Institutional holdings change Accumulating +702.1% (+34.07K sh)
Institutional value change Up +556.6%

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 6 SEC-registered investment managers reported holding GDTC (CYTOMED THERAPEUTICS LIMITED) in their latest 13F filings, with a combined reported value of $115.67K across 135.90K shares. That is +702.1% by share count (+34.07K shares) versus the previous quarter, while reported value moved +556.6%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 4 opened new positions, 1 added to existing stakes, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of CYTOMED THERAPEUTICS LIMITED (GDTC) include Citadel Advisors, UBS Group AG, SUSQUEHANNA INTERNATIONAL GROUP, LLP, ranked by reported 13F value among the 12 institutional holders on this page.

GDTC is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 6 135.90K $115.67K +702.1%
Q2 2026 3 11.88K $12.24K -21.8%
Q1 2026 3 16.34K $16.34K +471.2%
Q4 2025 5 53.13K $70.78K -92.0%
Q3 2025 2 18.12K $36.07K -24.4%
Q2 2025 2 45.25K $98.49K +42.8%
Q1 2025 2 31.70K $70.31K +43.1%
Q4 2024 1 10.10K $34.33K +16454.1%

Over the 8 quarters shown, institutional share counts increased 1246% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (+16454.1%).

Top Institutional Holders (Q3 2026) — 6 funds

FundSharesValuePortfolio WeightChange
UBS Group AG 38.90K $32.79K 0.00% Add
SUSQUEHANNA INTERNATIONAL GROUP, LLP 31.40K $26.47K 0.00% New
StoneX Group Inc. 26.96K $24.45K 0.00% New
HRT FINANCIAL LP 25.64K $21.00K 0.00% New
TWO SIGMA SECURITIES, LLC 12.98K $10.94K 0.00% New
OSAIC HOLDINGS, INC. 21 $17 0.00% Hold

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 3 funds

FundSharesValuePortfolio WeightChange
Axiom Investment Management LLC 7.03K $7.24K 0.01% New
UBS Group AG 4.83K $4.98K 0.00% Reduce
OSAIC HOLDINGS, INC. 21 $21 0.00% Hold

Q1 2026 — 3 funds

FundSharesValuePortfolio WeightChange
XTX Topco Ltd 10.14K $10.14K 0.00% New
UBS Group AG 6.18K $6.18K 0.00% Add
OSAIC HOLDINGS, INC. 21 $21 0.00% Hold

Q4 2025 — 5 funds

FundSharesValuePortfolio WeightChange
SUSQUEHANNA INTERNATIONAL GROUP, LLP 29.83K $39.67K 0.00% New
TWO SIGMA SECURITIES, LLC 11.86K $15.83K 0.00% New
StoneX Group Inc. 10.36K $13.82K 0.00% New
UBS Group AG 1.06K $1.42K 0.00% Reduce
OSAIC HOLDINGS, INC. 21 $28 0.00% New

Q3 2025 — 2 funds

FundSharesValuePortfolio WeightChange
UBS Group AG 13.29K $26.45K 0.00% Reduce
Wealthspire Advisors, LLC 4.83K $9.62K 0.00% New

Q2 2025 — 2 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors 27.67K $58.94K 0.00% Add
UBS Group AG 17.58K $39.56K 0.00% Add

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 12 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q1 2024Q4 2023Q3 2023Q2 2023
UBS Group AG 38.90K 4.83K 6.18K 1.06K 13.29K 17.58K 14.45K 10.10K 61 — 3.50K 477 54
SUSQUEHANNA INTERNATIONAL GROUP, LLP 31.40K — — 29.83K — — — — — — — — —
StoneX Group Inc. 26.96K — — 10.36K — — — — — — — — —
HRT FINANCIAL LP 25.64K — — — — — — — — — — — —
TWO SIGMA SECURITIES, LLC 12.98K — — 11.86K — — — — — — — — —
OSAIC HOLDINGS, INC. 21 21 21 21 — — — — — — — — —
Citadel Advisors — — — — — 27.67K 17.25K — — — — — —
SUMMIT SECURITIES GROUP LLC — — — — — — — — — — — 5.41K —
XTX Topco Ltd — — 10.14K — — — — — — — — — —
Wealthspire Advisors, LLC — — — — 4.83K — — — — — — — —
Axiom Investment Management LLC — 7.03K — — — — — — — — — — —
Tower Research Capital LLC (TRC) — — — — — — — — — 13 882 — —

Download holders (CSV)

FAQ

Which funds hold GDTC?

As of 2026-Q3, 6 institutional funds reported holding GDTC (CYTOMED THERAPEUTICS LIMITED) in SEC 13F filings, with a combined reported value of $115.67K.

How many shares of GDTC do institutions own?

13F filers reported 135.90K shares of GDTC, worth $115.67K in aggregate at the end of 2026-Q3.

Is institutional ownership of GDTC rising or falling?

Share counts moved +702.1% versus the prior quarter — accumulation.

Who are the top institutional holders of GDTC?

The largest 13F holders are Citadel Advisors, UBS Group AG, SUSQUEHANNA INTERNATIONAL GROUP, LLP, StoneX Group Inc., HRT FINANCIAL LP; the top 25 are ranked at the top of this page.

Who are the major shareholders of CYTOMED THERAPEUTICS LIMITED?

The major shareholders of CYTOMED THERAPEUTICS LIMITED (GDTC) by reported 13F value are Citadel Advisors, UBS Group AG, SUSQUEHANNA INTERNATIONAL GROUP, LLP, StoneX Group Inc., HRT FINANCIAL LP, among 12 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own GDTC" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/GDTC/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →